Pharma fever grips dealmakers despite M&A spike and a frenzy IPO year

More than a dozen top bankers moved to strategic and M&A roles in pharmaceutical companies, spearheading mergers and acquisition as well as fundraising plans. They included Nitin Tandon, who joined as head business development, Asia Pacific, at Johnson & Johnson from Credit Suisse.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nxGAUF
via IFTTT